The Journal of Urology · 2023 · 56 citations · 12 references
MedicinePharmacotherapyUrologyAndrologyHemostasisVoiding DysfunctionErectile DysfunctionPlatelet FunctionPlatelet PhysiologySexual DysfunctionAutologous Platelet ConcentratesPlacebo-controlled Efficacy AssessmentPlatelet-rich Plasma Injection
PURPOSE: We assessed the safety and efficacy of 2 injections of platelet-rich plasma for treating mild to moderate erectile dysfunction by conducting a prospective, randomized, double-blind, placebo-controlled clinical trial. MATERIALS AND METHODS: Men with mild to moderate erectile dysfunction (International Index of Erectile Function scores 11-25) were randomized to receive either 2 injections of platelet-rich plasma or placebo separated by 1 month. Primary outcome was percentage of men meeting minimum clinically important difference at 1 month after the second injection. Secondary outcomes were change in International Index of Erectile Function at 1, 3, and 6 months, and changes in penile vascular parameters and adverse events at 6 months. RESULTS: = .756). There were no major adverse events and only 1 minor adverse event in each group. There were no changes in penile Doppler parameters from baseline to 6 months. CONCLUSIONS: The results of our prospective, double-blind, randomized, placebo-controlled clinical trial suggest that 2 injections of intracavernosal platelet-rich plasma separated by 1 month in men with mild to moderate erectile dysfunction is safe, but we found no difference in efficacy between platelet-rich plasma and placebo.
12
The effect of platelet-rich plasma on cavernous nerve regeneration in a rat model
Xiegang Ding, Shiwen Li, Xinmin Zheng et al. · Asian Journal of Andrology · 2009 · 133 citations · Full text
Medicine, Neuroscience, Surgery +16
Ana Carvalheira, Nuno Monteiro Pereira, João Marôco et al. · The Journal of Sexual Medicine · 2012 · 129 citations · Full text
Medicine, Pharmacotherapy, Urology +10